Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Beaten Down Stocks To Buy Now

In this article, we will be taking a look at the 5 best beaten down stocks to buy now. To read our detailed analysis of the US stock market and recent developments within it, you can go directly to see the 13 Best Beaten Down Stocks To Buy Now.

5. Enphase Energy, Inc. (NASDAQ:ENPH)

Number of Hedge Fund Holders: 50

Enphase Energy, Inc. (NASDAQ:ENPH) is a semiconductor materials and equipment company based in Fremont, California. The company designs and develops home energy solutions for the solar photovoltaic industry.

Vikram Bagri at Citigroup maintained a Buy rating and a $170 price target on Enphase Energy, Inc. (NASDAQ:ENPH) on September 18.

We saw 50 hedge funds long Enphase Energy, Inc. (NASDAQ:ENPH) in the second quarter, with a total stake value of $772.7 million.

Here’s what Carillon Tower Advisers said about Enphase Energy, Inc. (NASDAQ:ENPH) in its second-quarter 2023 investor letter:

Enphase Energy provides solar microinverters and energy storage solutions. The company’s shares lagged benchmark counterparts amid concerns surrounding a near-term moderation in the growth of residential solar installation in the United States. Despite this, the company possesses a market-leading position in its core microinverter product and remains wellpositioned over the long term to benefit from ongoing solar adoption trends. Additionally, Enphase is focused on growing its international presence while also unveiling new products that could provide the next tailwind to its growth story.”

Follow Enphase Energy Inc. (NASDAQ:ENPH)

4. Dollar General Corporation (NYSE:DG)

Number of Hedge Fund Holders: 57

A Buy rating and a $160 price target were maintained on Dollar General Corporation (NYSE:DG) by Kate McShane, an analyst at Goldman Sachs, on September 1.

Dollar General Corporation (NYSE:DG) is a consumer staples company. It provides various merchandise products through its discount retail stores.

There were 57 hedge funds long Dollar General Corporation (NYSE:DG) in the second quarter, with a total stake value of $1.6 billion.

Aristotle Atlantic Partners said the following about Dollar General Corporation (NYSE:DG) in its second-quarter 2023 investor letter:

“We sold our position in Dollar General, following a weaker-than-expected quarterly earnings report and a lowered earnings outlook. The company’s core consumer, while still employed, continues to be impacted by higher inflation. Additionally, we saw the negative impacts of lower-than-expected tax refunds and reductions in the Federal Supplemental Nutrition Assistance Program (SNAP). Dollar General remained committed to spending on customer experience and investing in price to help their customers through the tougher economic environment, as a result, reducing the earnings guidance by a greater amount than the sales reductions.”

Follow Dollar General Corp (NYSE:DG)

3. JD.Com, Inc. (NASDAQ:JD)

Number of Hedge Fund Holders: 64

JD.Com, Inc. (NASDAQ:JD) had 64 hedge funds long its stock in the second quarter. Their total stake value was $2 billion.

Citigroup’s Alicia Yap maintains a Buy rating and a $64 price target on JD.Com, Inc. (NASDAQ:JD) as of August 17.

JD.Com, Inc. (NASDAQ:JD) is a broad-line retail company that offers supply chain-based tech and services. It is based in China.

This is what Baron Funds said about JD.Com, Inc. (NASDAQ:JD) in its first-quarter 2023 investor letter:

JD.com, Inc. (NASDAQ:JD) is one of the three largest e-commerce platforms in China. Shares declined after the company reported a slowdown in fourth quarter sales and commented that deliberate culling of unprofitable SKUs would also be a drag on headline revenue growth in the first half of 2023. We believe the slowdown was driven by the peak in Chinese COVID lockdowns, which have since ended, and the elimination or reduction of unprofitable business is better for long-term margins and returns on capital. We remain investors.”

Follow Jd.com Inc. (NASDAQ:JD)

2. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 66

A Buy rating and an $84 price target were reiterated on Bristol-Myers Squibb Company (NYSE:BMY) shares on September 15 by Gregg Gilbert at Truist Securities.

A total of 66 hedge funds were long Bristol-Myers Squibb Company (NYSE:BMY) in the second quarter, with a total stake value of $1.7 billion.

Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company based in New York. It offers products for hematology, oncology, cardiovascular, and immunology diseases, among more.

Follow Bristol Myers Squibb Co (NYSE:BMY)

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 73

Pfizer Inc. (NYSE:PFE) is another pharmaceutical company on our list. It is based in New York.

Pfizer Inc. (NYSE:PFE) was spotted in the portfolios of 73 hedge funds in the second quarter. Their total stake value was $1.5 billion.

Louise Chen at Cantor Fitzgerald reiterated an Overweight rating and a $75 price target on Pfizer Inc. (NYSE:PFE) shares on September 18.

Diamond Hill Capital said the following about Pfizer Inc. (NYSE:PFE) in its second-quarter 2023 investor letter:

“Our bottom contributors in Q2 included health insurance company Humana, biopharmaceutical company Pfizer Inc. (NYSE:PFE) and global entertainment company Disney. Pharmaceutical giant Pfizer has been dealing with a decline in sales due to lower COVID vaccination levels. Additionally, in 2023, management is increasing spend as the company invests in new product launches. That said, we remain positive about the long-term company fundamentals.”

Follow Pfizer Inc (NYSE:PFE)

See also 10 Beaten Down Stocks Billionaires Are Loading Up On and 12 Best Beaten Down Stocks To Buy.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.